Puberty blocker trial will help reduce harm, says Cass report author

“But for me, following the clinical advice, basing future decisions on clinical evidence, is the right way to move forward in the context of me having received the most robust assurances about the safeguards which are in place to protect young people involved in this trial from receiving harm.”